Researchers from Leiden University Medical Center (LUMC) and the University of Florida have found hundreds of blood proteins in people with Duchenne muscular dystrophy (DMD) that reflect disease progression. Measuring these biomarkers is less invasive than physical tests or biopsies and could support more tailored treatment decisions and help identify suitable candidates for clinical trials.
Read moreA driving force
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.